Skip to main content

Articles By Jack Cush, MD

EULAR19.abstract.jpg (keep)

EULAR 2023 – Day 4 Report

05 June 2023

Day 4 was a half day closeout to the EULAR 2023 Congress.

Read Article

EULAR 2023 – Day 3 Report

02 June 2023

Day 3 was a sunny warm day in Milan at the 2023 EULAR Congress meeting. Here are a few of my favorite abstracts from today.

Read Article

EULAR 2023 – Day 2 Report

01 June 2023

Day 2 at the international EULAR Congress meeting is always bigger and busier. There were sessions on JIA therapies, crystal arthritis, novel drugs for SLE and Sjogren's, early RA and preclinical RA interventions, IgG4 disease, osteoporosis and the growth and application of artificial intelligence in medicine and rheumatology.

Read Article

EULAR 2023 – Day 1 Report

31 May 2023

EULAR 2023 launched today to crowds of attendees.  The opening Plenary session and presidential address by Dr.

Read Article

EULAR 2023: Featured Industry Presentations

30 May 2023

EULAR 2023 opens tomorrow, Wednesday May 31st, with hundreds of novel presentations and pivotal clinical trials, many being featured industry sponsored clinical trials and research on their novel agents. Below is a collection of the featured abstracts, and presentation times from EULAR 2023. 

Read Article

Colchicine and the Risk of Knee and Hip Replacement

30 May 2023

Treatment of osteoarthritis is a major unmet need, as there are few therapies effective at pain control and no options for disease modification; yet a new trial in Annals of Internal Medicine suggest that chronic low dose colchicine may alter disease progression and lower the risk of of total knee and total hip replacements.

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

Belimumab in Lupus Nephritis

29 May 2023

Belimumab is a B-lymphocyte stimulator (BLyS)-specific inhibitor that is FDA approved for the treatment of active lupus and lupus nephritis, based on a few pivotal trials; and now a metanalysis supports its use in active lupus nephritis.

Read Article

Orbitofrontal Cortex Implants to Assess Chronic Pain

29 May 2023

Nature Neuroscience reports a novel approach to assessing chronic neuropathic pain - intracranial electrodes in the anterior cingulate cortex and orbitofrontal cortex (OFC) to map chronic pain signaling. 

Read Article
RheumNow Podcast square

3-4-5 Rule (5.26.2023)

26 May 2023

Dr. Jack Cush reviews more than a dozen news, journal articles and RNL highlights from this past week on

Read Article

Prevalence of Psoriatic Arthritis, Spondyloarthritis and Rheumatoid Arthritis in Norway

25 May 2023

Recent reports have suggested a rising and unrecognized number of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) compared to rheumatoid arthritis (RA).

Read Article